Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical

27/04/2022 07:00

Apr 27 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2022        Mar 31, 2021     Dec 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             32.65               30.27           162.00    
                 (+7.9 pct)          (-5.1 pct)       (+4.3 pct)  
  Operating          4.85                4.69            27.00    
                 (+3.3 pct)          (-3.8 pct)       (+3.6 pct)  
  Recurring          5.10                5.19            28.20    
                 (-1.8 pct)          (+3.0 pct)       (+0.7 pct)  
  Net                3.47                3.63            20.20    
                 (-4.3 pct)          (-3.1 pct)       (+2.5 pct)  
  EPS             44.87 yen           46.42 yen       259.85 yen  
  Ann Div                             83.00 yen        85.00 yen  
  -Q2 div                             37.00 yen        38.00 yen  
  -Q4 div                             46.00 yen        47.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T